Dr. Susan Ray Durham, D.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 44801 Highway 17, Vernon, AL 35592 Phone: 205-695-9611 |
Jonathan Beasley Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 9574 Highway 18, Vernon, AL 35592 Phone: 205-695-1195 Fax: 205-695-1196 |
Teresa Herren Mobley, R.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 9574 Highway 18, Vernon, AL 35592 Phone: 205-695-1195 Fax: 205-695-1196 |
Mrs. Landon Childs Reeves, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 651 8th Street Ne, Vernon, AL 35592 Phone: 662-207-0609 |
Dr. Sam Farrell Durham Jr., D.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 44801 Highway 17, Vernon, AL 35592 Phone: 205-695-9611 |
Mr. Terry L Duke, R PH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 170 5th Street Southwest, Vernon, AL 35592 Phone: 205-695-7911 Fax: 205-695-7970 |
News Archive
The Department of Health and Human Services will make available $600 million in loans to help start these co-ops, which were authorized by the health law. Meanwhile, various regulations regarding the health law's coverage expansions are pending at the Office of Management and Budget.
A summit of more than 60 high-level policymakers, leaders and health experts have adopted a global plan aimed at tackling the growing cancer crisis in developing countries.
Building on its seven-year-old National Rural Health Mission (NRHM), India's government plans to launch the National Urban Health Mission (NUHM), which "will focus on improving health care delivery and public health systems," the Lancet reports.
ViroPharma Incorporated today announced that it has signed an agreement with Sanquin Blood Supply Foundation for rights to develop, file regulatory dossiers, and commercialize Cinryze(TM) (C1 esterase inhibitor [human]) for hereditary angioedema (HAE) as well as for potential new indications in certain European and rest of world (ROW) territories.
At the 17th Conference on Retroviruses and Opportunistic Infections (CROI), ViiV Healthcare presented new data across its broad range of investigational and current medicines for the treatment of HIV/AIDS. Highlighted data at the conference included an oral presentation on the investigational integrase inhibitor, S/GSK1349572, as well as data presentations on SELZENTRY® (maraviroc) and EPZICOM® (abacavir/lamivudine).
› Verified 9 days ago